ストックスクリーナーアプリを入手
65.08
4.50%
-3.07
アフターアワーズ：
64.99
-0.09
-0.14%
前日終値:
$68.15
開ける：
$68.01
24時間の取引高:
7.68M
Relative Volume:
1.39
時価総額：
$25.38B
収益：
$4.52B
当期純損益:
$720.70M
株価収益率:
36.22
EPS:
1.7968
ネットキャッシュフロー:
$1.06B
1週間 パフォーマンス:
-6.88%
1か月 パフォーマンス:
-8.31%
6か月 パフォーマンス:
-18.82%
1年 パフォーマンス:
-22.40%
1日の値動き範囲:
$64.88
$69.00
1週間の範囲:
$64.88
$70.68
52週間の値動き範囲:
$54.11
$93.25
Dexcom Inc Stock (DXCM) Company Profile
Compare DXCM vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DXCM
Dexcom Inc
|
65.08 | 26.58B | 4.52B | 720.70M | 1.06B | 1.7968 |
|
ABT
Abbott Laboratories
|
111.47 | 197.52B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
365.85 | 139.09B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
MDT
Medtronic Plc
|
100.88 | 129.59B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.12 | 108.96B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
76.44 | 46.04B | 5.88B | 1.34B | 799.60M | 2.3489 |
Dexcom Inc Stock (DXCM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-12 | ダウングレード | Barclays | Equal Weight → Underweight |
| 2025-12-02 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2025-11-25 | 開始されました | Evercore ISI | In-line |
| 2025-10-21 | 再開されました | Stifel | Buy |
| 2025-09-08 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2025-08-21 | 開始されました | Argus | Buy |
| 2025-06-16 | 開始されました | Truist | Buy |
| 2025-05-30 | 開始されました | Goldman | Buy |
| 2025-04-10 | 開始されました | Mizuho | Outperform |
| 2025-02-03 | アップグレード | Redburn Atlantic | Neutral → Buy |
| 2025-01-16 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2024-07-26 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-07-26 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2024-05-30 | 開始されました | Redburn Atlantic | Neutral |
| 2024-03-12 | 開始されました | RBC Capital Mkts | Outperform |
| 2023-05-30 | 再開されました | Morgan Stanley | Equal-Weight |
| 2023-04-17 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2023-03-29 | 開始されました | UBS | Buy |
| 2023-01-26 | 開始されました | Wolfe Research | Outperform |
| 2022-10-18 | 開始されました | Barclays | Equal Weight |
| 2022-10-12 | 開始されました | Jefferies | Buy |
| 2022-07-15 | 開始されました | Bernstein | Outperform |
| 2022-03-02 | 再開されました | BofA Securities | Buy |
| 2022-02-03 | アップグレード | BTIG Research | Neutral → Buy |
| 2022-01-19 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2022-01-07 | アップグレード | Guggenheim | Neutral → Buy |
| 2021-10-18 | ダウングレード | Guggenheim | Buy → Neutral |
| 2021-07-21 | 再開されました | Cowen | Outperform |
| 2021-05-28 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2021-05-25 | 開始されました | Barclays | Overweight |
| 2021-04-15 | 開始されました | Atlantic Equities | Overweight |
| 2021-01-06 | アップグレード | UBS | Neutral → Buy |
| 2020-10-02 | ダウングレード | Wells Fargo | Equal Weight → Underweight |
| 2020-05-27 | 繰り返されました | Piper Sandler | Overweight |
| 2020-05-14 | 開始されました | Wells Fargo | Equal Weight |
| 2020-03-05 | 開始されました | Citigroup | Buy |
| 2019-11-07 | 繰り返されました | Canaccord Genuity | Buy |
| 2019-11-07 | アップグレード | Guggenheim | Neutral → Buy |
| 2019-10-23 | 開始されました | Stifel | Buy |
| 2018-11-28 | 開始されました | UBS | Neutral |
| 2018-10-19 | アップグレード | Goldman | Sell → Neutral |
| 2018-09-12 | アップグレード | Northland Capital | Under Perform → Market Perform |
| 2018-08-02 | 繰り返されました | Canaccord Genuity | Buy |
| 2018-07-02 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2018-06-08 | アップグレード | JP Morgan | Neutral → Overweight |
| 2018-05-11 | 開始されました | BofA/Merrill | Buy |
| 2018-05-03 | 繰り返されました | Canaccord Genuity | Buy |
| 2018-04-04 | 開始されました | Goldman | Sell |
| 2018-04-04 | 開始されました | Guggenheim | Neutral |
| 2018-03-23 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2018-01-04 | ダウングレード | Northland Capital | Market Perform → Under Perform |
| 2017-09-28 | 繰り返されました | Wedbush | Outperform |
すべてを表示
Dexcom Inc (DXCM) 最新ニュース
Dexcom beats Street in Q4 on 13% sales growth - massdevice.com
DexCom Q4 Adjusted Earnings, Revenue Rise; 2026 Outlook Reiterated - marketscreener.com
DexCom: Q4 Earnings Snapshot - WKYC
Earnings Flash (DXCM) DexCom, Inc. Posts Q4 Adjusted EPS $0.68 per Share, vs. FactSet Est of $0.65 - marketscreener.com
Dexcom Reports Fourth Quarter and Fiscal Year 2025 Financial Results - TradingView
DexCom (NASDAQ:DXCM) Exceeds Q4 CY2025 Expectations - Yahoo! Finance Canada
DexCom Inc. Bottom Line Rises In Q4 - Nasdaq
Dexcom Stock in Focus: Can the Glucose Sensor Pioneer Regain Its Former Highs? - AD HOC NEWS
Will DexCom Inc outperform the market in YEARWeekly Earnings Recap & Reliable Momentum Entry Alerts - baoquankhu1.vn
DexCom earnings up next: Can G7 rollout offset Abbott competition? By Investing.com - Investing.com Nigeria
DexCom, Inc. (NASDAQ:DXCM) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
DexCom Stelo AI Upgrade Aims To Deepen Consumer Metabolic Health Engagement - Yahoo Finance
Dexcom Q4 2025 earnings preview - MSN
Earnings Preview: DexCom - Benzinga
What Are Wall Street Analysts' Target Price for DexCom Stock? - Barchart.com
DexCom, Inc. $DXCM Shares Sold by ProShare Advisors LLC - MarketBeat
DexCom, Inc. $DXCM Shares Acquired by ING Groep NV - MarketBeat
Will DXCM Deliver Q4 Earnings Beat on G7 Stabilization, Volume Growth? - TradingView
Weekly Trades: Is DexCom Inc a strong growth stock2025 Market Trends & Accurate Intraday Trading Signals - baoquankhu1.vn
Countdown to DexCom (DXCM) Q4 Earnings: Wall Street Forecasts for Key Metrics - Yahoo Finance
Envestnet Asset Management Inc. Grows Stock Position in DexCom, Inc. $DXCM - MarketBeat
Allianz Asset Management GmbH Acquires 47,234 Shares of DexCom, Inc. $DXCM - MarketBeat
Earnings To Watch: DexCom (DXCM) Reports Q4 Results Tomorrow - Finviz
DexCom upgraded at Morgan Stanley on sorting out operational issues - MSN
DexCom’s AI Powered Stelo Pushes Deeper Into Consumer Metabolic Health - Yahoo Finance
August 21st Options Now Available For DexCom (DXCM) - Nasdaq
Principal Financial Group Inc. Cuts Stock Holdings in DexCom, Inc. $DXCM - MarketBeat
Bessemer Group Inc. Has $41.98 Million Stake in DexCom, Inc. $DXCM - MarketBeat
A Look Into DexCom Inc's Price Over Earnings - Sahm
DexCom Expands Stelo AI Tools As It Seeks Stickier CGM Users - Sahm
DexCom (DXCM) Reports Next Week: Wall Street Expects Earnings Growth - Finviz
DXCM Upgrades Stelo With AI-Powered Smart Meal Logging Features - TradingView
Growth Value: Should I average down on DexCom Inc stockWeekly Risk Report & Risk Adjusted Swing Trade Ideas - baoquankhu1.vn
Thrivent Financial for Lutherans Buys 48,749 Shares of DexCom, Inc. $DXCM - MarketBeat
DexCom (DXCM) to Release Earnings on Thursday - MarketBeat
DexCom’s CEO Believes Diabetics On GLP-1s Should Also Wear CGMs - MedCity News
Dexcom adds enhanced smart meal logging feature to Stelo CGM - MassDevice
Stelo Adds Enhanced Smart Meal Logging Features as Dexcom Continues to Transform Personal Glucose Management - Eagle-Tribune
Continuous Glucose Monitoring Devices Market to Reach US$10.72 - openPR.com
Does DexCom (NASDAQ:DXCM) Have A Healthy Balance Sheet? - 富途牛牛
New Dexcom CEO Takes on ‘Thrilling’ Task Leading CGM Giant - San Diego Business Journal
Continuous Glucose Monitoring Market to Grow at a Robust CAGR - openPR.com
Peterson Wealth Services Grows Stock Position in DexCom, Inc. $DXCM - MarketBeat
DexCom, Inc. (DXCM) Stock Analysis: Exploring a 16.64% Upside Potential in the Growing Medical Devices Sector - DirectorsTalk Interviews
What DexCom (DXCM)'s Strong Q4 Beat and Margin Guidance Means For Shareholders - Sahm
DexCom Faces Split Analyst Views As Competition Pressures Core CGM Markets - Sahm
DexCom’s Q4 Beat And 2026 Targets Tested By Rising CGM Competition - Yahoo Finance
What DexCom (DXCM)'s Strong Q4 Beat and 2026 Margin Guidance Means For Shareholders - Yahoo Finance
DexCom, Inc. $DXCM Shares Purchased by Mirae Asset Global Investments Co. Ltd. - MarketBeat
Q4 Preliminary Figures and 2026 Guidance Make DexCom (DXCM) Look Attractive - Insider Monkey
Investigation into DexCom's Corporate Governance Breaches - Intellectia AI
Dexcom Inc (DXCM) 財務データ
収益
当期純利益
現金流量
EPS
0.31%
2.06%
大文字化:
|
ボリューム (24 時間):